These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33884654)

  • 81. Canine non-B, non-T NK lymphocytes have a potential antibody-dependent cellular cytotoxicity function against antibody-coated tumor cells.
    Kim Y; Lee SH; Kim CJ; Lee JJ; Yu D; Ahn S; Shin DJ; Kim SK
    BMC Vet Res; 2019 Oct; 15(1):339. PubMed ID: 31610784
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Release of pig leukocytes and reduced human NK cell recruitment during ex vivo perfusion of HLA-E/human CD46 double-transgenic pig limbs with human blood.
    Puga Yung G; Bongoni AK; Pradier A; Madelon N; Papaserafeim M; Sfriso R; Ayares DL; Wolf E; Klymiuk N; Bähr A; Constantinescu MA; Voegelin E; Kiermeir D; Jenni H; Rieben R; Seebach JD
    Xenotransplantation; 2018 Jan; 25(1):. PubMed ID: 29057510
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Proliferation of functional human natural killer cells with anti-HIV-1 activity in NOD/SCID/Jak3(null) mice.
    Hattori S; Matsuda K; Kariya R; Harada H; Okada S
    Microbiol Immunol; 2016 Feb; 60(2):106-13. PubMed ID: 26708420
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Expression of HLA class I-specific natural killer cell receptors on peripheral blood mononuclear cells during graft-versus-host disease after allogeneic bone marrow transplantation.
    Tanaka J; Tsutsumi Y; Zhang L; Kato N; Mori A; Ohta S; Toyoshima N; Asaka M; Imamura M
    Transplant Proc; 2003 Feb; 35(1):497-8. PubMed ID: 12591503
    [No Abstract]   [Full Text] [Related]  

  • 85. Cytokine-induced killer cells: NK-like T cells with cytotolytic specificity against leukemia.
    Linn YC; Hui KM
    Leuk Lymphoma; 2003 Sep; 44(9):1457-62. PubMed ID: 14565644
    [TBL] [Abstract][Full Text] [Related]  

  • 86. A single-nucleotide polymorphism in the human ENTPD1 gene encoding CD39 is associated with worsened graft-versus-host disease in a humanized mouse model.
    Adhikary SR; Cuthbertson P; Turner RJ; Sluyter R; Watson D
    Immunol Cell Biol; 2020 May; 98(5):397-410. PubMed ID: 32181525
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Allogeneic MHC-mismatched activated natural killer cells administered after bone marrow transplantation provide a strong graft-versus-leukaemia effect in mice.
    Zeis M; Uharek L; Glass B; Steinmann J; Dreger P; Gassmann W; Schmitz N
    Br J Haematol; 1997 Mar; 96(4):757-61. PubMed ID: 9074419
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Anti-ovarian tumor response of donor peripheral blood mononuclear cells is due to infiltrating cytotoxic NK cells.
    Pandey V; Oyer JL; Igarashi RY; Gitto SB; Copik AJ; Altomare DA
    Oncotarget; 2016 Feb; 7(6):7318-28. PubMed ID: 26802025
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Adoptive therapy by transfusing expanded donor murine natural killer T cells can suppress acute graft-versus-host disease in allogeneic bone marrow transplantation.
    Yang J; Gao L; Liu Y; Ren Y; Xie R; Fan H; Qian K
    Transfusion; 2010 Feb; 50(2):407-17. PubMed ID: 19788510
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Human T cells depend on functional calcineurin, tumour necrosis factor-α and CD80/CD86 for expansion and activation in mice.
    Søndergaard H; Kvist PH; Haase C
    Clin Exp Immunol; 2013 May; 172(2):300-10. PubMed ID: 23574326
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD).
    Cao T; Soto A; Zhou W; Wang W; Eck S; Walker M; Harriman G; Li L
    Cell Immunol; 2009; 258(1):65-71. PubMed ID: 19410243
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Xenogeneic Graft-Versus-Host Disease in Humanized NSG and NSG-HLA-A2/HHD Mice.
    Ehx G; Somja J; Warnatz HJ; Ritacco C; Hannon M; Delens L; Fransolet G; Delvenne P; Muller J; Beguin Y; Lehrach H; Belle L; Humblet-Baron S; Baron F
    Front Immunol; 2018; 9():1943. PubMed ID: 30214443
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Donor-specific prolongation of rat skin graft survival induced by rat-donor cells and cyclophosphamide under coadministration of monoclonal antibodies against T cell receptor alpha beta and natural killer cells in mice.
    Umesue M; Mayumi H; Nishimura Y; Kong YY; Omoto K; Murakami Y; Nomoto K
    Transplantation; 1996 Jan; 61(1):116-24. PubMed ID: 8560549
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Role of alloreactive natural killer cell in mouse MHC haploidentical bone marrow transplantation].
    He Y; Wang HH; Wang M; Zhou Z; Zhai WJ; Huang Y; Jiang EL; Wang ZD; Zhou SY; Liu QG; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):82-6. PubMed ID: 16732957
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Long-term human CD34+ stem cell-engrafted nonobese diabetic/SCID/IL-2R gamma(null) mice show impaired CD8+ T cell maintenance and a functional arrest of immature NK cells.
    André MC; Erbacher A; Gille C; Schmauke V; Goecke B; Hohberger A; Mang P; Wilhelm A; Mueller I; Herr W; Lang P; Handgretinger R; Hartwig UF
    J Immunol; 2010 Sep; 185(5):2710-20. PubMed ID: 20668220
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The P2X7 receptor antagonist Brilliant Blue G reduces serum human interferon-γ in a humanized mouse model of graft-versus-host disease.
    Geraghty NJ; Belfiore L; Ly D; Adhikary SR; Fuller SJ; Varikatt W; Sanderson-Smith ML; Sluyter V; Alexander SI; Sluyter R; Watson D
    Clin Exp Immunol; 2017 Oct; 190(1):79-95. PubMed ID: 28665482
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Reduction of GVHD and enhanced antitumor effects after adoptive infusion of alloreactive Ly49-mismatched NK cells from MHC-matched donors.
    Lundqvist A; McCoy JP; Samsel L; Childs R
    Blood; 2007 Apr; 109(8):3603-6. PubMed ID: 17179231
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Human NK cell infusions prolong survival of metastatic human neuroblastoma-bearing NOD/scid mice.
    Castriconi R; Dondero A; Cilli M; Ognio E; Pezzolo A; De Giovanni B; Gambini C; Pistoia V; Moretta L; Moretta A; Corrias MV
    Cancer Immunol Immunother; 2007 Nov; 56(11):1733-42. PubMed ID: 17426969
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Natural Killer Cells Prevent the Formation of Teratomas Derived From Human Induced Pluripotent Stem Cells.
    Benabdallah B; Désaulniers-Langevin C; Colas C; Li Y; Rousseau G; Guimond JV; Haddad E; Beauséjour C
    Front Immunol; 2019; 10():2580. PubMed ID: 31787975
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Comparative Immunogenomics of Canine Natural Killer Cells as Immunotherapy Target.
    Gingrich AA; Reiter TE; Judge SJ; York D; Yanagisawa M; Razmara A; Sturgill I; Basmaci UN; Brady RV; Stoffel K; Murphy WJ; Rebhun RB; Brown CT; Canter RJ
    Front Immunol; 2021; 12():670309. PubMed ID: 34594320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.